Linked Life Data

16911691

Source:http://linkedlifedata.com/resource/pubmed/id/16911691

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
2006-8-16
pubmed:abstractText
Antimitochondrial autoantibodies (AMA) are known to be a hallmark of primary biliary cirrhosis, and it has been suggested that AMA play a crucial role in generating biliary changes. Biliary tract lesions are not uncommon in patients with autoimmune hepatitis (AIH) and previous works have demonstrated that AMA are occasionally detectable in sera of patients with AIH. Therefore, the role of AMA as a cause of bile duct lesions in AIH livers should be addressed. The aim of the present study was to determine whether the presence of AMA is associated with clinical features, especially the occurrence of bile duct lesions, in patients with AIH.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0815-9319
pubmed:author
pubmed:issnType
Print
pubmed:volume
21
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1448-54
pubmed:meshHeading
pubmed:year
2006
pubmed:articleTitle
Presence of antimitochondrial autoantibodies in patients with autoimmune hepatitis.
pubmed:affiliation
Third Department of Internal Medicine, School of Medicine, Kyorin University, Tokyo, Japan. saeko@kyorin-u.ac.jp
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't